ASX Announcements

29 May, 2020

THC Global establishes presence in growing CBD market

21 May, 2020

THC Global medicinal cannabis product available via prescription in Australia

12 May, 2020

THC Global acquires leading clinic network Tetra Health

4 May, 2020

THC Global Quarterly Update & Appendix 4C

1 Apr, 2020

Confirmation of Release – THC – 2019 Annual Report

3 Mar, 2020

Production commenced to support 6,000 Australian Patients

2 Mar, 2020

Appendix 4E Preliminary Final Report for the Year Ended 31 December 2019

10 Feb, 2020

Launch of Australian and International Medicines Supply

31 Jan, 2020

THC Global Quarterly Update & Appendix 4C 31 January 2020

21 Jan, 2020

TGA GMP Manufacturing Licence Granted for Southport Facility

20 Jan, 2020

THC – Product Supply Agreement Signed with MGC Pharma

4 Dec, 2019

First Medicinal Cannabis Processed at Southport Facility

19 Nov, 2019

THC Global Shareholder Update 19 November 2019

11 Nov, 2019

Manufacturing Permit Received for Southport Facility

30 Oct, 2019

THC Global Quarterly Update & Appendix 4C 30 September 2019

21 Oct, 2019

THC Global Builds New Zealand CBD Presence

17 Oct, 2019

THC Global Two Facilities Receive S4 and S8 Narcotics Licences

24 Sep, 2019

THC Global Group Limited Corporate Presentation September 2019

23 Sep, 2019

THC Global Limited (ASX:THC) Change of Address

5 Sep, 2019

THC Global Group secures 24.6ha cannabis cultivation site

2 Sep, 2019

2019 THC Half Yearly Report and Accounts

29 Aug, 2019

THC Global Group Limited Southport Facility Opened by Federal Minister for Health

31 Jul, 2019

THC Global THC Global Quarterly Update & Appendix 4C 31 July 2019

9 Jul, 2019

Eve Investments – THC Global Agreement Update

9 Jul, 2019

THC Global Southport Manufacturing Facility Licenced

13 Jun, 2019

THC Global Granted Cannabis Manufacture Licence

28 May, 2019

Results of Annual General Meeting

28 May, 2019

Chairman’s Address

15 May, 2019

THC Global Expands Cultivation & Export Licence Granted

6 May, 2019

THC Global SPP Completed & Appendix 3B

1 May, 2019

THC Global Quarterly Update & Appendix 4C 30 April 2019

23 Apr, 2019

Notice of Annual General Meeting 28 May 2019

18 Apr, 2019

THC Global April 2019 Share Purchase Plan Update

17 Apr, 2019

THC Global Hydroponic Equipment Operations Update

10 Apr, 2019

THC Global Group Share April 2019 Purchase Plan – Offer Documents

5 Apr, 2019

THC Global Launches Share Purchase Plan

5 Apr, 2019

THC Global Continues Global Expansion – Asia Strategy

29 Mar, 2019

THC Global Group Limited Consolidated Financial Report 31 December 2018

26 Mar, 2019

Canadian Cannabis Production Site Acquisition Completed

28 Feb, 2019

THC Global Group Limited Appendix 4E 2018 Preliminary Financial Report

1 Feb, 2019

THC Global Corporate Update – January 2019 and Appendix 4C

15 Jan, 2019

Appointment of Group Chief Financial Officer

21 Dec, 2018

Australian Cannabis Permits Granted to THC Global

28 Nov, 2018

THC Global Expands into New Zealand Medicinal Cannabis Market

28 Nov, 2018

Issue of Securities Following Shareholder Approval & Apps 3Y

22 Nov, 2018

THC ASX Announcement 22 November 2018 change of name to THC Global Group Limited

22 Nov, 2018

THC ASX Announcement Canadian Cannabis Growing Facility Binding Agreement Signed

15 Nov, 2018

Results of EGM

2 Nov, 2018

First Australian Patients Prescribed Endoca CBD Products

31 Oct, 2018

THC Quarterly Update 31 October 2018

16 Oct, 2018

THC Positioned for Canadian Recreational Cannabis

12 Oct, 2018

THC Limited Investor Update

12 Oct, 2018

Notice of Extraordinary Meeting/Proxy Form

30 Aug, 2018

2018 THC Half Yearly Reports and Accounts

30 Aug, 2018

Change of Company Secretary and Registered Company Offices

31 Jul, 2018

Australian Patients Can Now Access Endoca Medicinal Cannabis

30 Jul, 2018

Canadian Hydroponics Division and Restatement of Objectives

11 Jul, 2018

Acquisition Delivers $16m to Balance Sheet & MC Strategy

11 Jul, 2018

THC Appoints CEO & Experienced Medicinal Cannabis Team

9 Jul, 2018

THC Executes Initial Cooperation Agreement With Endoca

6 Jul, 2018

THC North American Update

28 Jun, 2018

Cannabis Strains Exchange with Canadian Licensed Producer

26 Jun, 2018

Appointment of Product & Regulatory Affairs Manager

25 Jun, 2018

Inaugural Shipment of Medicinal Cannabis Received from Endoca

21 Jun, 2018

Final Hurdle Cleared For Legalisation Of Recreational Cannabis In Canada

8 Jun, 2018

THC Rec Ready – Canada Passes Recreational Cannabis Law

7 May, 2018

THC Australian Operations Update

4 May, 2018

Australian Canadian Clinic Rollout Halted

3 May, 2018

THC Secures Additional Site for Medicinal Cannabis Growth and Supply Agreements

26 Apr, 2018

THC Acquires Australian Biomanufacturing Facility

26 Apr, 2018

Appendix 4C – March Quarterly

12 Apr, 2018

Shareholder Update: Executive Team Appointed

23 Mar, 2018

AGM Chairman’s Address to Shareholders

23 Mar, 2018

Results of Annual General Meeting

23 Mar, 2018

2018 AGM Presentation

16 Mar, 2018

2018 AGM Update and Revised Proxy Forms

15 Mar, 2018

Results of EGM

14 Mar, 2018

Resignation of Chief Executive Officer

13 Mar, 2018

Resignation of Chief Commercial Officer

2 Mar, 2018

2017 Annual Report

2 Mar, 2018

THC Welcomes Simplified Access to Medicinal Cannabis in NSW

2 Mar, 2018

Canada Update

28 Feb, 2018

Granting of Endoca Import Permits and Clinical Trial Support

28 Feb, 2018

Appendix 4E – Preliminary Final Report

15 Feb, 2018

Queensland Growing Facility Update

13 Feb, 2018

Notice of Inaugural Annual General Meeting and Proxy Forms

8 Feb, 2018

ASIC Consent to Extension of Time to Hold Inaugural AGM

8 Feb, 2018

Company Response to EGM Notice Issued by Alan Beasley

7 Feb, 2018

Clinic Rollout Update

6 Feb, 2018

Chairman’s Letter and Notice of Meeting from A Beasley

31 Jan, 2018

Quarterly Company Update

24 Jan, 2018

Canadian Business Update

19 Jan, 2018

SPP Update

16 Jan, 2018

Australian Business Update

12 Jan, 2018

Appointment of new director

12 Jan, 2018

Meetings of Shareholders

5 Jan, 2018

THC To Import First Medicinal Cannabis Products In Early 2018 & Welcomes Fed Gov Export Approval

21 Dec, 2017

Exclusive Distribution Agreement with Nanolux Technology

14 Dec, 2017

Successful Share Placement and SPP

7 Dec, 2017

THC Announces Licensing Agreement with National Access Canada – Leading Clinic Chain in Canada

29 Nov, 2017

THC Shareholder Update

21 Nov, 2017

THC Appoints Chief Commercial Officer

20 Nov, 2017

THC Enters Partnership With Israeli Medicinal Cannabis Pioneer, BOL Pharma

15 Nov, 2017

Distribution Agreement Signed with Major European Supplier

13 Nov, 2017

THC Investor Presentation – November 2017

30 Oct, 2017

Medicinal Cannabis Licence Recieved

27 Oct, 2017

September Quarterly Activities Report

19 Oct, 2017

Group CEO Appointment, New Chairman and Board Changes

5 Sep, 2017

Executive Team – International Business and Prospects Report

1 Sep, 2017

Partnership for National Roll Out of Medicinal Cannabis Facilitated Prescribing and Dispensing

31 Aug, 2017

2017 Half Yearly Results and Accounts

16 Aug, 2017

Appointment of Company Secretary and Chief Financial Officer

2 Aug, 2017

Quarterly Business Review

13 Jul, 2017

Medicinal Cannabis Licences – Update

11 Jul, 2017

Medicinal Cannabis Research Licence Granted

20 Jun, 2017

Shareholder Update

6 Jun, 2017

Updated Investor Presentation

24 May, 2017

Strategic Alliance Formed with US-Based Pharmaceutical Company

16 May, 2017

Proactive Investor Presentation

11 May, 2017

Medicinal Cannabis CEO to Present at Investor Forum

Connect
Healthcare Professionals
Hydroponics
Medicinal Cannabis
About
Investors
Connect

© 2020 All rights reserved – THC Global Group Limited ACN 614 508 039 Website Policy

Web design by Mastery Websites

© 2020 All rights reserved – The Hydroponics Company Limited ACN 614 508 039 Website Policy
Web design by Mastery Websites